跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ADVATE octocog alfa rch 2000 IU intravenous injection vial
Approved
STANDARD
ADVATE octocog alfa rch 2000 IU intravenous injection vial
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
24a716207d6b9acd
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
24a716207d6b9acd
Product Name
ADVATE octocog alfa rch 2000 IU intravenous injection vial
Artg Id
136204
Artg Name
ADVATE octocog alfa (rch) 2000 IU powder for injection vial with diluent vial
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2008-01-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fff99473ff0138e81c0b7b3b1c78729e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/17fa12580409c0d11ea1243a003b6d6d.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
24a716207d6b9acd
Type
Standard
Back to TGA Approvals
ADVATE octocog alfa rch 2000 IU intravenous injection vial - TGA Drug Approval Details